S100A8 and prostate carcinoma: By using mass-spectrometry, gel electrophoresis and Western blot analyses, the pro-inflammatory S100A8/A9 were found to be a major proteinaceous component of all corpora amylacea specimens obtained as a result of prostatectomy of the prostate cancer patients [15].